This inventor holds 31 USPTO granted patents, plus 1 CIPO patent, primarily in Hematopoietic Stem Cell Expansion. Top assignees: G.d. Searle & Company, Monsanto Company, Washington University. Active years: 1993-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ballwin, MO (US) (1993 - 1996)
- Lafayette, MO (US) (1998)
- Superior, MO (US) (2000)
- Superior, CO (US) (2000 - 2001)
- Lafayette, CO (US) (2000 - 2002)
- Glencoe, MO (US) (1994 - 2006)
Company Filing History:
18 out of 1,323 
2 out of 3,289 
2 out of 1,381 
Years Active: 1993-2006
Areas of Expertise:
Title: Innovations and Contributions of Inventor Peter O. Olins
Introduction: Peter O. Olins, based in Glencoe, MO, is a noteworthy inventor holding an impressive portfolio of 31 patents. His contributions primarily focus on advancements in biotechnology and pharmaceuticals, particularly in relation to interleukin-3 variants and their applications in hematopeitic stem cell research.
Latest Patents: Among his latest patents, Olins has developed innovative fusion proteins that comprise human interleukin-3 (hIL-3) variant proteins functionally linked to other cytokines or colony stimulating factors. These fusion molecules, designed with specific amino acid substitutions and deletions, solve crucial challenges in pharmaceutical compositions. Furthermore, he has outlined methods for utilizing interleukin-3 mutant polypeptides for the ex-vivo expansion of hematopoietic stem cells. His recent inventions also include recombinant expression vectors comprising nucleotide sequences responsible for encoding these hIL-3 muteins, which offer enhanced biological activities and improved side effect profiles.
Career Highlights: Olins has notably contributed to significant advancements in the field through his tenure at G.D. Searle & Company, where he worked on pioneering pharmaceutical innovations. His role encompassed extensive research efforts that helped bridge the gap between basic research and clinical applications.
Collaborations: Throughout his career, Peter O. Olins has collaborated with esteemed colleagues including Alan Michael Easton and John Patrick McKearn. These partnerships have facilitated the development of groundbreaking technologies and formulations, significantly impacting the areas of immunology and stem cell therapies.
Conclusion: Peter O. Olins stands out as an innovative inventor in the biotechnology field, consistently contributing to enhancements in pharmaceutical sciences. With his extensive patent portfolio and collaborative efforts, he continues to pave the way for future breakthroughs in medicine and therapeutics. The significance of his work lies not only in his individual achievements but also in the potential benefits those innovations hold for medical research and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile